Natural history of moderate aplastic anemia in children

Pediatric Blood & Cancer
Scott C HowardWinfred C Wang

Abstract

Moderate aplastic anemia (MAA) in children is a rare, idiopathic condition of bone marrow insufficiency that can resolve spontaneously, persist for months or years, or progress to severe aplastic anemia (SAA). We evaluated the rate of progression to SAA. We reviewed the records of 136 children referred for evaluation of bone marrow failure from 1978 to 2002 at St. Jude Children's Research Hospital. MAA was defined by a hypocellular bone marrow (<50%) and 2 or 3 cytopenias (absolute neutrophil count <1,500/mm(3), absolute reticulocyte count <40,000/mm(3), platelet count <100,000/mm(3)) lasting at least 6 weeks. Twenty-four patients met the criteria for MAA. At a median follow-up of 66 months (range, 10-293), 16 patients (67%) progressed to SAA, 5 (21%) had persistent MAA, and 3 (12%) had complete resolution of MAA. No risk factors for progression could be identified. When childhood MAA is treated with supportive care alone, 2/3 of patients progress to SAA.

References

Jan 1, 1990·The American Journal of Pediatric Hematology/oncology·M H Freedman
Jan 1, 1985·Critical Reviews in Oncology/hematology·A M Gewirtz, R Hoffman
Mar 25, 1982·The New England Journal of Medicine·B M CamittaE D Thomas
Jan 1, 1997·Southern Medical Journal·J A KingL F Latour
Feb 17, 2000·Seminars in Hematology·N Frickhofen, S J Rosenfeld
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Stephen RosenfeldNeal S Young

❮ Previous
Next ❯

Citations

Apr 4, 2009·International Journal of Hematology·Nobuhiro NishioSeiji Kojima
Jun 5, 2010·International Journal of Hematology·Ji Hyun KwonByoung-Kook Kim
Jan 31, 2013·International Journal of Hematology·Shuchun WangXiaofan Zhu
May 12, 2005·Lancet·Robert A Brodsky, Richard J Jones
Apr 9, 2008·Current Opinion in Hematology·Neal S YoungRodrigo T Calado
Jun 17, 2006·Blood·Neal S YoungPhillip Scheinberg
Mar 23, 2011·Haematologica·Takuya KamioUNKNOWN Japan Childhood Aplastic Anemia Study Group
Jul 7, 2009·Pediatric Hematology and Oncology·Shayi JiangXiaotian Xie
Jan 8, 2016·Pediatric Blood & Cancer·Seth J Corey
Nov 19, 2013·Pediatric Clinics of North America·Helge D HartungMonica Bessler
Mar 31, 2009·Hematology/oncology Clinics of North America·Eva C Guinan
Feb 12, 2005·Pediatric Blood & Cancer·Peter KurreH Joachim Deeg
Jan 12, 2007·British Journal of Haematology·Jeffrey K Davies, Eva C Guinan
Nov 17, 2017·Current Treatment Options in Oncology·Scott A PeslakDaria V Babushok
Feb 1, 2020·British Journal of Haematology·Bhumika J PatelJaroslaw P Maciejewski
Apr 25, 2020·Blood Advances·Xing FanCynthia E Dunbar
Jul 4, 2020·Journal of Paediatrics and Child Health·Eliska Furlong, Tina Carter
Aug 21, 2020·Journal of Pediatric Hematology/oncology·Jillian LapinskiRobert H Squires

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.